SCHEMBL1269703

SCHEMBL1269703

Cc1cc(Sc2ccc(S(=O)(=O)N3CCCCC3)cc2)nnc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 1/20 0.44
▸ ALDH1A1 P00352 5/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ATM Q13315 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ LMNA P02545 5/20 0.40
▸ GAA P10253 3/20 0.40
▸ HTT P42858 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ HCRTR1 O43613 1/20 0.38
▸ HCRTR2 O43614 1/20 0.38
▸ MCL1 Q07820 3/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ PIK3C3 Q8NEB9 1/20 0.37
▸ MAPT P10636 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ SCN9A Q15858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269954 0.86 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AL3MBTL1TSHR
SCHEMBL1269481 0.83 ALDH1A1 (0.43) CCKBRALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1269747 0.81 ALDH1A1 (0.42) CCKBRALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1269584 0.80 ALDH1A1 (0.43) CCKBRALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1269926 0.79 ALDH1A1 (0.46) CCKBRALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1268542 0.79 ALDH1A1 (0.42) CCKBRALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1268625 0.75 ALDH1A1 (0.39) CCKBRALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1269038 0.74 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AL3MBTL1TSHR
SCHEMBL1269552 0.74 ALDH1A1 (0.38) CCKBRALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1269559 0.74 ALDH1A1 (0.38) CCKBRALDH1A1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG CCKBR 1384/4885ALDH1A1 2237/4885MEN1 4841/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG CCKBR 1384/4885ALDH1A1 2237/4885MEN1 4841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback